Skip to content

ESMO Congress 2026

October 23–27, 2026 · Madrid · 1920 items

← All topics

#INSIGHTSBYESMO

2 people · 2 posts

Heat trend for this story

Heat now 0·Peak in the comparable set 1 (Oct 23 21:00)·Change over 24h in the comparable set –·Participants now 1

Participants counted1
00.250.50.751
Heat over time
00.250.50.751Oct23Oct24Oct24Oct24
Floor
  1. Philippe Aftimos, MD 

    Analysis by @PTarantinoMD in this #InsightsbyESMO article https://x.com/myesmo/status/2113880715762741474?s=46

    引用@

    🔹Small improvement in mPFS with pembrolizumab (vs placebo) + chemotherapy in the KN-B49 ph3 study for endocrine resistant, PDL1+ (CPS≥1) HR+/HER2- MBC 🔹Bigger difference in CPS≥10: small numbers and a secondary endpoint 🔹No OS difference #ESMO2 #ESMOAmbassadors @myESMO

    Same topic #INSIGHTSBYESMO · 2 people22 views0 likes0 reposts0 replies
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org